Cellebrite Di Ltd. (CLBT) executive Thomas E. Hogan plans large share sale

Rhea-AI Filing Summary

Cellebrite Di Ltd. filed a notice that Thomas E. Hogan intends to sell ordinary shares, par value NIS 0.00001, through Morgan Stanley Smith Barney LLC on or around 08/12/2026, with trading on Nasdaq. The shares to be sold were acquired from Cellebrite Di Ltd. on 08/11/2026 as Performance Shares granted as employee compensation. During the prior three months, Hogan sold ordinary shares on 07/02/2026, with 103,188 shares reported sold for total consideration of 1625892.04.

Key Figures

Shares linked to planned sale: 339484 shares Planned sale date: 08/12/2026 Shares sold in prior 3 months: 103188 shares +2 more

5 metrics

Shares linked to planned sale 339484 shares Ordinary shares, par value NIS 0.00001, referenced in Form 144

Planned sale date 08/12/2026 Approximate date of sale for ordinary shares

Shares sold in prior 3 months 103188 shares Ordinary shares sold on 07/02/2026

Value of prior sale 1625892.04 Total consideration for 103,188 ordinary shares sold on 07/02/2026

Grant date of Performance Shares 08/11/2026 Acquisition date of Performance Shares as employee compensation

Key Terms

Performance Shares, Employee Compensation, Securities Sold During The Past 3 Months, Form 144

4 terms

Performance Shares financial

"08/11/2026 | Performance Shares | CELLEBRITE DI LTD."

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Employee Compensation financial

"339484 | 08/11/2026 | Employee Compensation"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 regulatory

"144: Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 04:18 PM Accepted by SEC EDGAR 08/11/2026 - 04:17 PM Learn about SEC filing dates

FAQ

What share sale is disclosed for Cellebrite (CLBT) in this Form 144?

The filing discloses that Thomas E. Hogan plans to sell Cellebrite ordinary shares through Morgan Stanley Smith Barney LLC on or around 08/12/2026, with the shares listed for trading on Nasdaq.

How many Cellebrite (CLBT) shares are linked to the planned sale?

The notice references 339,484 ordinary shares in connection with the planned sale. These shares were granted as Performance Shares to Thomas E. Hogan as part of employee compensation from Cellebrite Di Ltd. on 08/11/2026.

When were the Cellebrite (CLBT) shares to be sold originally acquired?

The shares were acquired on 08/11/2026 as Performance Shares from Cellebrite Di Ltd.. The acquisition is classified as Employee Compensation, indicating they were granted as part of Hogan’s compensation package rather than purchased in the market.

What prior Cellebrite (CLBT) share sales by Thomas E. Hogan are reported?

Over the past three months, the filing reports a sale on 07/02/2026 of 103,188 ordinary shares, par value NIS 0.00001, for total consideration of 1625892.04. This transaction is recorded under securities sold during the past three months.

Which broker and exchange are associated with the Cellebrite (CLBT) planned share sale?

The planned sale is associated with Morgan Stanley Smith Barney LLC Executive Financial Services as broker, located at 1 New York Plaza, New York. The ordinary shares are identified for trading on the Nasdaq exchange.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	339484	5397796	248581042	08/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	08/11/2026	Performance Shares	CELLEBRITE DI LTD.			339484	08/11/2026	Employee Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
THOMAS E. HOGAN 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	07/02/2026	103188	1625892.04

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)